Accession | ARO:3007022 |
Definition | Prulifloxacin is a 6-fluoroquinolone antibiotic with a C-2 sulfur atom. It is hydrolyzed by esterases to produce the active compound Ulifloxacin. The active compound has broad spectrum activity against most Gram-negative bacteria. Prulifloxacin displays strong bactericidal activity against Pseudomonas aeruginosa biofilms and persister cells. |
SMILES | Cc1oc(=O)oc1CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)c2n3C(C)S2)CC1 |
PubChem | 65947 |
ChEMBL | CHEMBL422648 |
ChEBI | 32071 |
CAS | 123447-62-1 |
Drug Class | fluoroquinolone antibiotic |
Classification | 2 ontology terms | Show |
Parent Term(s) | 1 ontology terms | Show + fluoroquinolone antibiotic [Drug Class] |
Publications | Ozaki M, et al. 1991. Antimicrob Agents Chemother 35(12):2496-9 In vivo evaluation of NM441, a new thiazeto-quinoline derivative. (PMID 1667252) Tougou K, et al. 1998. Drug Metab Dispos 26(4):355-9 Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent. (PMID 9531524) She P, et al. 2021. Curr Microbiol 79(1):12 Repurposing Sitafloxacin, Prulifloxacin, Tosufloxacin, and Sisomicin as Antimicrobials Against Biofilm and Persister Cells of Pseudomonas aeruginosa. (PMID 34905092) |
Curator | Description | Most Recent Edit |
---|